News GENinCode Plc

Equities

GENI

GB00BL97B504

Market Closed - London S.E. Other stock markets 11:35:01 2024-05-10 EDT			5-day change	1st Jan Change
9.625 ^GBX	+4.05%		+30.51%	+83.33%

04-04	GENinCode Plc Announces Publication by the American Journal of Preventive Cardiology of A Study on 'Polygenic Risk and Incident Heart Disease in a Large Multiethnic Cohort	CI
03-21	GENinCode says ROCA recommended as ovarian cancer risk test in England	AN

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

GENinCode Plc Announces Publication by the American Journal of Preventive Cardiology of A Study on 'Polygenic Risk and Incident Heart Disease in a Large Multiethnic Cohort	04-04	CI
GENinCode says ROCA recommended as ovarian cancer risk test in England	03-21	AN
GENinCode gets GBP57,000 in retail offer, well below maximum	12-28	AN
GENinCode Raises GBP4 Million from Share Sale	12-28	MT
GENinCode raises GBP4 million via placing and subscription	12-21	AN
Genincode Plc Announces Placing And Subscription To Raise A Minimum Of £4.0 Mln	12-21	RE
Aura eyes Tiris expansion; Kavango backs Pambili	11-29	AN
GENinCode plc Agrees with the Food and Drug Administration to Create New Regulatory Class for Polygenic Risk scores and Transition Its Premarket Notification 510(K) Submission to A De Novo Pathway	11-29	CI
EARNINGS: ASA interim profit plummets; Mycelx loss narrows, revenue up	23-09-20	AN
Earnings Flash (GENI.L) GENINCODE Reports H1 Revenue GBP950,000	23-09-20	MT
Earnings Flash (GENI.L) GENINCODE Posts H1 Loss GBX-3.33	23-09-20	MT
GENinCode Plc Provides Revenue Guidance for the Second Half of 2023	23-09-20	CI
GENinCode Plc Reports Earnings Results for the Half Year Ended June 30, 2023	23-09-20	CI
Genincode plc Announces CARDIO inCode study on risk of incident Coronary Heart Disease	23-08-30	CI
GENinCode Shares Rise on FDA Filing for Heart Disease Test Kit	23-08-16	DJ
GENinCode Submits Premarket Notification for US Commercial Distribution of Polygenic Test Kit	23-08-16	MT
GENinCode plc Files its Premarket Notification with the Food and Drug Administration to Expand Its US Commercial Distribution of the Cardio InCode-Score Polygenic Test for the Risk Assessment and Prevention of Coronary Heart Disease	23-08-16	CI
Certain Ordinary Shares of GENinCode Plc are subject to a Lock-Up Agreement Ending on 23-JUL-2023.	23-07-22	CI
GENinCode Shares Rise Amid US Partnership with MedStar Health	23-07-19	MT
GENinCode and MedStar collaborate on coronary heart disease testing	23-07-19	AN

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News GENinCode Plc

Equities

GENI

GB00BL97B504

Summary

Filters